Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Victhom Human Bionics Inc V.VHB



TSXV:VHB - Post by User

Post by JABombardieron Apr 26, 2009 12:32pm
173 Views
Post# 15945413

VHB: Any idea who this US Company could be???

VHB: Any idea who this US Company could be???Like I said...Victhom choose partenership very carefully...like OSSUR for Power Knee II....Neurostep....will be ????


https://www.victhom.com/docs/news/56.2005-10-06_en.pdf


VICTHOM ENTERS INTO COLLABORATIVE DEVELOPMENT

AGREEMENT WITH A U.S.-BASED MEDICAL DEVICE LEADER

Quebec City, Quebec (Canada), Tuesday, October 11, 2005 – Victhom Human

Bionics Inc., "Victhom" (TSX: VHB) announces today that they have entered into a

collaborative contract research agreement with one of the world leader in the Medical

Device market to develop an advanced implantable stimulation product to address

growing medical market opportunities. The platform behind this innovative product

development program is Victhom’s Bionic Closed-Loop System (CLS) and, under the

terms of the collaboration, will also integrate technologies from Victhom’s new U.S.-

based partner.

Potential markets that could be addressed using Victhom’s Bionic CLS include, among

others, bladder control, digestive tract stimulation and chronic pain management. As

previously disclosed, Victhom is actively conducting its development activities for the use

of the Bionic CLS to address the urinary incontinence market.

Financial terms, name of the partner and details of the development plan will not be

disclosed at this time for competitive reasons.

About Victhom

Victhom specializes in the development and commercialization of bionic devices aimed

at improving the quality of life of individuals suffering from physical dysfunctions. The

Company has 82 employees and three research units: BioTronix, NeuroBionix and

MetoBionix.

Victhom manages a portfolio of more than 25 patents and 12 registered trademarks. The

Company has established an ongoing process to ensure the protection of its intellectual

property and to pursue aggressively new filings and new partnership agreements.

* Forward-looking statements contained in this press release involve known and unknown risks,

uncertainties or other factors that may cause actual results, performance or achievements of the

company to be materially different from any future results, performance or achievements

expressed or implied by such forward-looking statements.

-30-

Source: Victhom Human Bionics Inc.

For more information: Benoit Côte

President and CEO

Victhom Human Bionics Inc.

Phone: + (418) 872-5665, ext. 103

benoit.cote@victhom.com

Simon Poitras

HKDP

Tel.: (418) 523-3352, ext. 239

spoitras@hkdp.qc.ca

<< Previous
Bullboard Posts
Next >>